IRF5 and systemic lupus erythematosus: Paradoxically, in SLE, IRF5 improves systemic lipid profiles by lowering very low-density lipoprotein (VLDL) and elevating high-density lipoprotein (HDL) levels, highlighting its context-dependent functionality (80).